A recent portrait of bioactive triazoles

Current Bioactive Compounds

Volumn 6, Issue 4, 2010, Pages 208-242

  Pibiri, I ^a   Buscemi, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Antibacterial; Antifungal; Antitumor; Antiviral; Click reaction; Enzyme inhibitor; Triazole

Indexed keywords

CHITINASE; CYCLOOXYGENASE 2; PROTEIN TYROSINE KINASE; TRIAZOLE DERIVATIVE;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANDIDA ALBICANS; DRUG CYTOTOXICITY; DRUG SYNTHESIS; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; HUMAN; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 78649993430     PISSN: 15734072     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340710793237281     Document Type: Article

References (104)

1. Demirbaş, N.; Ugurluoglu, R.; Demirbaş, A. Synthesis of 3- Alkyl(Aryl)-4-alkylidenamino-4,5-dihydro1H-1,2,4-triazol-5-ones and 3-Alkyl-4-alkylamino-4,5-dihydro1H-1,2,4-triazol-5-ones as Antitumor Agents. Bioorg. Med. Chem., 2002, 10, 3717-3723.
2. Al-Saud, Y.A.; Al-Dweri, M.N.; Al-Masoudi, N.A. Synthesis, antitumor and antiviral properties of some1,2,4-triazole derivatives. Farmaco, 2004, 59, 775-783.
3. Shivarama Holla, B.; Veerendra, B.; Shivananda, M.K.; Poojary, B. Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur. J. Med. Chem., 2003, 38, 759-767.
4. Pagliai, F.; Pirali, T.; Del Grosso, E.; Di Brisco, R.; Tron, G.C.; Sorba, G.; Genazzani, A.A. Rapid synthesis of triazole-modified resveratrol analogues via click chemistry. J. Med. Chem., 2006, 49, 467-470.
5. Li, J.; Zheng, M.; Tang, W.; He, P.-L.; Zhu, W.; Li, T.; Zuo, J.-P.; Liu, H.; Jian, H. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities. Bioorg. Med. Chem. Lett., 2006, 16, 5009-5013.
6. Kritsanida, M.; Mouroutsou, A.; Marakos, P.; Pouli, N.; Papakonstantinou-Garoufalias, S.; Pannecouque, C.; Witvrouw, M.; De Clercq, E. Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. Farmaco, 2002, 57, 253-257.
7. Tozkoparan, B.; Gökhan, N.; Aktay, G.; Yeşilada, E.; Ertan, M. 6- Benzylidenethiazolo[3,2-b]-1,2,4-triazole-5(6H)-ones substituted with ibuprofen: synthesis, characterization and evaluation of anti-inflammatory activity. Eur. J. Med. Chem., 2000, 34, 743-750.
8. Turan-Zitouni, G.; Kaplancikli, Z.A.; Erol, K.; Kiliç, F.S. Synthesis and analgesic activity of some triazoles and triazolothiadiazines. Farmaco, 1999, 54, 218-223.
9. Ersan, S.; Nacak, S.; Berkem, R. Synthesis and antimicrobial activity of N-[(α-methyl)benzylidene]-(3-substituted-1,2,4-triazol-5-ylthio) acetohydrazides. Farmaco, 1998, 53, 773-776.
10. Shivarama Holla, B.; Gonsalves, R.; Shennoy, S. Studies on some N-bridged heterocycles derived from bis-[4-amino-5-mercapto-1,2,4-triazol-3-yl] alkanes. Farmaco, 1998, 53, 574-578.
11. Demirbaş, N.; Karaoglu, S.A.; Demirbaş, A.; Sancak, K. Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives. Eur. J. Med. Chem., 2004, 39, 793-804.
12. Ram, V. J.; Pandey, H. N. Synthesis of 5-membered heterocycles and related compounds. Chem. Pharm. Bull., 1974, 22, 2778-2783.
13. Ergenc, N.; Ilhan, E.; Otuk, G. Synthesis and activity of some 1,4-disubstituted thiosemicarbazides and their 1,2,4-triazole-5-thione derivative. Pharmazie, 1992, 47, 59-60.
14. Moreno-Manas, M.; Arredondo, Y.; Pleixats, R.; Teixido, M.; Raga, M.M.; Palacin, C.; Castello, J.M.; Oritiz, J.A. New triazole antifungal agents derived from mercaptomethylisoxazoles. J. Hetero. Chem., 1992, 29, 1557-560.
15. Whiting, M.; Muldoon, J.; Lin, Y.C.; Silverman, S.M.; Lindstron, W.; Olson, A.J.; Kolb, H.C.; Finn, M.G.; Sharpless, K.B.; Elder, J.H.; Fokin, V.V. Inhibitors of HIV-1 protease by using in situ click chemistry. Angew. Chem. Int. Ed., 2006, 45, 1435-1439.
16. Tornøe, C.W.; Sanderson, S.J.; Mottram, J.C.; Coombs, G.H.; Meldal, M. Combinatorial library of peptidotriazoles: Identification of [1,2,3]-triazole inhibitors against a recombinant Leishmania mexicana cysteine protease. J. Comb. Chem., 2004, 6, 312-324.
17. Tron, G.C.; Pirali, T.; Billington, R.A.; Canonico, P.L.; Sorba, G.; Genazzani, A.A. Click chemistry reactions in medicinal chemistry: Applications of the 1,3-dipolar cycloaddition between azides and alkynes. Med. Res. Rev., 2008, 28, 278-308.
18. Duncia, J.V.; Santella, J.B. III; Higley, C.A.; VanAtten, M.K.; Weber, P.C.; Alexander, R.S.; Kettner, C.A.; Pruitt, J.R.; Liauw, A.Y.; Quan, M.L.; Knabb, R.M.; Wexler, R.R. Pyrazoles, 1,2,4-triazoles and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors. Bioorg. Med. Chem. Lett., 1998, 8, 775-780.
19. Somu, R.V.; Boshoff, H.; Qiao, C.; Bennett, E.M.; Barry, C.E. III; Aldrich, C.C. Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis. J. Med. Chem., 2006, 49, 31-34.
20. Pirali, T.; Gatti, S.; Di Brisco, R.; Tacchi, S.; Zaninetti, R.; Brunelli, E.; Massarotti, A.; Sorba, G.; Canonico, P.L.; Moro, L.; Genazzani, A.A.; Tron, G.C.; Billington, R.A. Estrogenic analogues synthesized via click chemistry. ChemMedChem, 2007, 2, 437-440.
21. Bennet, I.S.; Brooks, G.; Broom, N.J.P.; Calvert, S.H.; Coleman, K.; Francois, I. 6-(Substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. J. Antibiotics, 1991, 44, 969-977.
22. Bennett, I.; Broom, N.J.P.; Bruton, G.; Calvert, S.; Clarke, B.P.; Coleman, K.; Edmondson, R.; Edwards, P.; Jones, D.; Osborne, N.F.; Walker, G. 6-(Substituted methylene)penenms, potent broad spectrum inhibitors of bacterial beta lactamase. J. Antibiotics, 1991, 44, 331-337.
23. Kume, M.; Kubota, T.; Kimura, Y.; Nakashimizu, K.; Motokawa, M.; Nakano, M. Synthesis and structure-activity relationship of new 7-beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyminoacetamido]-cephalosporins with 1,2,3-triazole in C-3 side chain. J. Antibiotics, 1993, 46, 177-192.
24. Makabe, O.; Suzuki, H.; Umezawa, S. Synthesis of Darabinofuranosyl and 20-deoxy-D-ribofuranosyl 1,2,3-triazolecarboxamides. Bull. Chem. Soc. Jpn., 1977, 50, 2689-2693.
25. Alonso, R.; Camarasa, M.J.; Alonso, G.; De Las Heras, F.G. Synthesis and cytostatic activity of N-ribosylhalomethyl-1,2,3 triazoles. Eur. J. Med. Chem., 1980, 15, 105-109.
26. Guo, L.; Ye, C.; Chen, W.; Ye, H.; Zheng, R.; Li, J.; Yang, H.; Yu, X.; Zhang, D. Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent. J. Pharm. Exp. Therap., 2008, 325, 10-16.
27. Schafer, H.; Gewald, K.; Bellmann, P.; Gruner, M. Synthesis and reactions of 2-arylhydrazono-2-cyano-N,N-dialkylacetamidines. Monatsh. Chem., 1991, 122, 195-207.
28. Bel'skaya, N.P.; Demina, M.A.; Sapognikova, S.G.; Fan, Z.-J.; Zhang, H.-K.; Dehaenc, W.; Bakulev V.A. Synthesis and oxidative cyclization of 2-arylhydrazono-2cyanoacetamidines to 5-amino-2-aryl-2H-[1,2,3]triazole-4-carbonitrile. ARKIVOC, 2008, xvi, 9-21.
29. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem. Int. Ed., 2002, 41, 2596-2599.
30. Tornøe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem., 2002, 67, 3057-3064.
31. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Click chemistry: Diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. Engl., 2001, 40, 2004-2021.
32. Aucagne, V.; Leigh, D. Chemoselective formation of successive triazole linkages in one pot: "click-click"chemistry. Org. Lett., 2006, 8, 4505-4507.
33. Peng, W.; Feldman, A.K.; Nugent, A.K.; Hawker, C.J.; Scheel, A.; Voit, B.; Pyun, J.; Fréchet, J.M.J.; Sharpless, K.B.; Fokin, V.V. Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(I)-catalyzed ligation of azides and alkynes. Angew. Chem. Int. Ed., 2004, 43, 3928-3932.
34. Malkoch, M.; Schleicher, K.; Drockenmuller, E.; Hawker, C.J.; Russell, T.P.; Wu, P.; Fokin, V.V. Structurally diverse dendritic libraries: A highly efficient functionalization approach using click chemistry. Macromolecules, 2005, 38, 3663-3678.
35. Zhang, L.; Chen, X.; Xue, P.; Sun, H.H.Y.; Williams, I.D.; Sharpless, K.B.; Fokin, V.V.; Jia, G. Ruthenium-catalyzed cycloaddition of alkynes and organic azides. J. Am. Chem. Soc., 2005, 127, 15998-15999.
36. Majireck, M.M.; Weinreb, S.M. A study of scope and regioselectivity of the ruthenium-catalyzed [3+2]-cycloaddition of azides with internal alkynes. J. Org. Chem., 2006, 71, 8680-8683.
37. Chen, H.; Taylor, J.L.; Abrams, S.R. Design and synthesis of bmethoxyacrylate analogues via click chemistry and biological evaluations. Bioorg. Med. Chem. Lett., 2007, 17, 1979-1983.
38. Sauter, H.; Steglich, W.; Anke, T. Strobilurins: Evolution of a new class of active substances. Angew. Chem. Int. Ed., 1999, 38, 1328-1349.
39. Aufort, M.; Herscovici, J.; Bouhours, P.; Moreau, N.; Girard, C. Synthesis and antibiotic activity of a small molecules library of 1,2,3-triazole derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 1195-1198.
40. Da Silva, E.N. Jr.; Menna-Barreto, R.F.S.; Do Carmo, M.; Pinto, F.R.; Silva, R.S.F.; Teixeira, D.V.; De Souza, M.C.B.V.; De Simone, C.A.; De Castro, S.L.; Ferreira, V.F.; Pinto, A.V. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi. Eur. J. Med. Chem., 2008, 43, 1774-1780.
41. Zhou, Y.; Zhao, Y.; O'Boyle, K.M.; Murphy, P.V. Hybridangiogenesis inhibitors: Synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin andaryl-1,2,3-triazoles. Bioorg. Med. Chem. Lett., 2008, 18, 954-958.
42. Kallander, L.S.; Lu, Q.; Chen, W.; Tomaszek, T.; Yang, G.; Tew, D.; Meek, T.D.; Hofmann, G.A.; Schulz-Pritchard, C.K.; Smith, W.W.; Janson, C.A.; Ryan, M.D.; Zhang, G.-F.; Johanson, K.O.; Kirkpatrick, R.B.; Ho, T.F.; Fisher, P.W.; Mattern, M.R.; Johnson, R.K.; Hansbury, M.J.; Winkler, J.D.; Ward, K.W.; Veber, D.F.; Thompson, S.K. 4-Aryl-1,2,3-triazole: A novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo. J. Med. Chem., 2005, 48, 5644-5647.
43. Pili, R.; Chang, J.; Partis, R.A.; Mueller, R.A.; Chrest, F.J.; Passaniti, A. The α-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res., 1995, 55, 2920-2926.
44. Nguyen, M.; Folkman, J.; Bischoff, J. 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine capillary endothelial cells. J. Biol. Chem., 1992, 267, 26157-26165.
45. Stockwell, B.R. Exploring biology with small organic molecules. Nature, 2004, 432, 846-854.
46. Smukste, I.; Stockwell, B.R. Advances in chemical genetics. Ann. Rev. Genomics Hum. Genet., 2005, 6, 261-286.
47. Spring, D.R. Chemical genetics to chemical genomics: small molecules offer big insights. Chem. Soc. Rev., 2005, 34, 472-482.
48. Huisgen, R. 1,3-Dipolar cycloadditions. Past and future. Angew. Chem. Int. Ed. Engl., 1963, 2, 565-598.
49. Bock, V.D.; Hiemstra, H.; van Maarseveen, J.H. CuI-catalyzed alkyne-azide click cycloadditions from a mechanistic and synthetic perspective. Eur. J. Org. Chem., 2006, 51-68.
50. Ritschel, J.; Sasse, F.; Maier M.E. Synthesis of a benzolactone collection using click chemistry. Eur. J. Org. Chem., 2007, 78-87.
51. 99mTc(CO)3-labeled N(τ)-histidine folate derivative with Its isostructural, clicked 1,2,3-triazole analogue. Bioconjug. Chem., 2008, 19, 1689-1695.
52. Salmon, A.J.; Williams, M.L.; Innocenti, A.; Vullo, D.; Supuran, C.T.; Poulsen, S.-A. Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety. Bioorg. Med. Chem. Lett., 2007, 17, 5032-5035.
53. Poulsen, S.-A.; Wilkinson, B.L.; Innocenti, A.; Vullo, D.; Supuran, C.T. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 4624-4627.
54. Wilkinson, B.L.; Bornaghi, L.F.; Houston, T.A.; Innocenti, A.; Vullo, D.; Supuran, C.T.; Poulsen, S.-A. Inhibition of membraneassociated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides. Bioorg. Med. Chem. Lett., 2007, 17, 987-992.
55. Wilkinson, B.L.; Bornaghi, L.F.; Houston, T.A.; Innocenti, A.; Vullo, D.; Supuran, C.T.; Poulsen S.-A. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked Oglycosides of benzene sulfonamides. J. Med. Chem., 2007, 50, 1651-1657.
56. Wilkinson, B.L.; Innocenti, A.; Vullo, D.; Supuran, C.T.; Poulsen S.-A. Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. J. Med. Chem., 2008, 51, 1945-1953.
57. Supuran, C.T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov., 2008, 7, 168-181.
58. Pastorekova, S.; Parkkila, S.; Pastorek, J.; Supuran, C.T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem., 2004, 19, 199-229.
59. Supuran, C.T.; Scozzafava, A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg. Med. Chem., 2007, 15, 4336-4350.
60. Supuran, C.T. Carbonic anhidrases: catalytic and inhibition mechanisms, distribution and physiological roles. In: Supuran, C.T.; Scozzafava, A.; Conway, J.; Eds. Carbonic anhydrase: its inhibitors and activators. CRC Press: Boca Raton - FL, 2004, pp. 1-24.
61. Borras, J.; Alzuet, G.; Ferrer, S.; Supuran, C.T. Metal complexes of heterocyclic sulfonamides as carbonic anhidrase inhibitors. In: Supuran, C.T.; Scozzafava, A.; Conway, J.; Eds. Carbonic anhydrase: its inhibitors and activators. CRC Press: Boca Raton - FL, 2004, pp. 183-208.
62. Bruce, M.I.; Hall, B.C.; Zaitseva, N.N.; Skelton, B.W.; White, A.H. Preparation and reactions of some neutral pentamethylcyclopentadienyl-ruthenium vinylidene complexes. J. Chem. Soc., Dalton Trans., 1998, 1793-1804.
63. Cheng, Z.-Y; Li, W.-J.; He, F.; Zhou, J.-M.; Zhu, X.-F. Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3triazoles as inhibitor of HER2 tyrosine kinase. Bioorg. Med. Chem., 2007, 15, 1533-1538.
64. Hirose, T.; Sunazuka, T.; Sugawara, A.; Endo, A.; Iguchi, K.; Yamamoto, T.; Ui, H.; Shiomi, K.; Watanabe, T.; Sharpless, K.B.; Omura, S. Chitinase inhibitors: extraction of the active framework from natural argifin and use of in situ click chemistry. J. Antibiot., 2009, 62, 277-282.
65. Omura, S.; Arai, N.; Yamaguchi, Y.; Masuma, R.; Iwai, Y.; Namikoshi, M.; Turberg, A.; Kölbl, H.; Shiomi, K. Argifin, a new chitinase inhibitor, produced by Gliodadium sp. FTD-0668. I. Taxonomy, fermentation, and biological activities. J. Antibiot., 2000, 53, 603-608.
66. Arai, N.; Shiomi, K.; Iwai, Y.; Omura, S. Argifin, a new chitinase inhibitor, produced by Gliodadium sp. FTD-0668. II. Isolation, physico-chemical properties, and structure elucidation. J. Antibiot. 2000, 53, 609-614.
67. Shiomi, K.; Arai, N.; Iwai, Y.; Turberg, A.; Kölbl, H.; Omura, S. Structure of argifin, a new chitinase inhibitor produced by Gliocladium sp. Tetrahedron Lett., 2000, 41, 2141-2143.
68. Arai, N.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Iwai, Y.; Turberg, A.; Koelbl, H.; Omura, S. Argadin, a new chitinase inhibitor, produced by Clonostachys sp. FO-7314. Chem. Pharm. Bull., 2000, 48, 1442-1446.
69. Li, J.J.; Norton, M.B.; Reinhard, E.J.; Anderson, G.D.; Gregory, S.A.; Isakson, P.C.; Koboldt, C.M.; Masferrer, J.L.; Perkins, W.E.; Seibert, K.; Zhang, Y.; Zweifel, B.S.; Reitz, D.B. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J. Med. Chem., 1996, 39, 1846-1856.
70. Amir, M.; Kumar, H.; Javed, S.A. Non-carboxylic analogues of naproxen: design, synthesis, and pharmacological evaluation of some 1,3,4-oxadiazole/thiadiazole and 1,2,4-triazole derivatives. Arch. Pharm. Chem. Life Sci., 2007, 340, 577-585.
71. Kumar, H.; Javed, S.A.; Khan, S.A.; Amir M. 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: Synthesis and preliminary evaluation of biological properties. Eur. J. Med. Chem., 2008, 43, 2688-2698.
72. Turan-Zitouni, G.; Kaplancikli, Z.A.; Özdemir, A.; Chevallet, P.; Kandilci, H.B.; Gümüsel, B. Studies on 1,2,4-triazole derivatives as potential anti-inflammatory agents. Arch. Pharm. Chem. Life Sci., 2007, 340, 586-590.
73. Tozkoparan, B.; Küpeli, E.; Yeşilada, E.; Ertan, M. Preparation of 5-aryl-3-alkylthio-l,2,4-triazoles and corresponding sulfones with antiinflammatory-analgesic activity. Bioorg. Med. Chem., 2007, 15, 1808-1814.
74. Gökhan, N.; Erdoǧan, H.; Durlu, N.T.; Demirdamar, R. Analgesic activity of acylated 2-benzoxazolinone derivatives. Farmaco, 1999, 54, 112-115.
75. Çaliş, Ü.; Gökhan, N.; Erdoǧan, H. Synthesis of some novel 3-methyl-6-(2-substitutedpropanoyl/propyl)-2-benzoxazolinone derivatives and anti-nociceptive activity. Farmaco, 2001, 56, 719-724.
76. Jund, L.; Corse, J.; King, A.S.; Bayne, H.; Mihrag, K. Antimicrobial properties of 6,7-dihydroxy-, 7,8-dihydroxy-, 6-hydroxy- and 8-hydroxycoumarins. Phytochemistry, 1971, 10, 2971-2974.
77. Salgin-Gökşen, U.; Gökhan-Kelekçi, N.; Göktaş, Ö.; Köysal, Y.; Kiliç, E.; Işik, Ş.; Aktay G.; Özalp, M. 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, analgesic-antiinflammatory and antimicrobial activities. Bioorg. Med. Chem., 2007, 15, 5738-5751.
78. Khanmohammadi, H.; Abnosi, M.H.; Hosseinzadeh, A.; Erfantalab, M. Synthesis, biological and computational study of new Schiff base hydrazones bearing 3-(4-pyridine)-5-mercapto-1,2,4-triazole moiety. Spectrochim. Acta Part A: Mol. Biomol. Spectr., 2008, 71, 1474-1480.
79. Havaldar, F.H.; Patil, A.R. Syntheses of 1, 2, 4 triazole derivatives and their biological activity. E-J. Chem., 2008, 5, 347-354.
80. Ezabadi, I.R.; Camoutsis, C.; Zoumpoulakis, P.; Geronikaki, A.; Sokovic, M.; Glamocilija, J.; Ciric, A. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg. Med. Chem., 2008, 16, 1150-1161.
81. Couladis, M.; Tzakou, O.; Kujundzic, S.; Sokovic, M.; Mimica-Dukic, N. Chemical analysis and antifungal activity of Thymus striatus. Phytother. Res., 2004, 18, 40-42.
82. Yang, C.-L.; Wang, X.-F.; Jin, Z.-P.; Meng F.-G.; Xu S.-P. Synthesis, crystal structure and biological activity of 1-(β-Dglucopyranosyl)-3-amino-5-methyl-1H-1,2,4-triazole. Chinese J. Struct. Chem., 2009, 28, 471-476.
83. Bagihalli, G.B.; Gouda Avaji, P.; Patil, S.A.; Badami, P.S. Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. Eur. J. Med. Chem., 2008, 43, 2639-2649.
84. Sadana, A.K.; Miraza, Y.; Aneja, K.R.; Prakash, O. Hypervalent iodine mediated synthesis of 1-aryl/hetryl-1,2,4triazolo[4,3-a]pyridines and 1-aryl/hetryl 5-methyl-1,2,4-triazolo[4,3a]quinolines as antibacterial agents. Eur. J. Med. Chem., 2003, 38, 533-536.
85. Ducki, S.; Mackenzie, G.; Lawrence, N.J.; Snyder, J.P. Quantitative structure-activity relationship (5D-QSAR) study of combretastatinlike analogues as inhibitors of tubulin assembly. J. Med. Chem., 2005, 48, 457-465.
86. Zhang, Q.; Peng, Y.; Wang, X.I.; Keenan, S.M.; Arora, S.; Welsh, W.J. Highly potent triazole-based tubulin polymerization inhibitors. J. Med. Chem., 2007, 50, 749-754.
87. Lin, C.M.; Singh, S.B.; Chu, P.S.; Dempcy, R.O.; Schmidt, J.M.; Pettit, G.R.; Hamel, E. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol. Pharmacol., 1988, 34, 200-208.
88. Pettit, G.R.; Rhodes, M.R.; Herald, D.L.; Hamel, E.; Schmidt, J.M.; Pettit, R.K. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41. J. Med. Chem., 2005, 48, 4087-4099.
89. McGown, A.T.; Fox, B.W. Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines. Cancer Chemother. Pharmacol., 1990, 26, 79-81.
90. Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Hatanaka, T.; Morinaga, Y.; Nihei, Y.; Ohishi, K.; Suga, Y.; Akiyama, Y.; Tsuji, T. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. J. Med. Chem., 1998, 41, 3022-3032.
91. Nam, N.H. Combretastatin A-4 analogues as antimitotic antitumor agents. Curr. Med. Chem., 2003, 10, 1697-1722.
92. Tron, G.C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A.A. Medicinal chemistry of combretastatin A4: present and future directions. J. Med. Chem., 2006, 49, 3033-3044.
93. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A.K.; Lin, C.M.; Hamel, E. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. J. Med. Chem., 1991, 34, 2579-2588.
94. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.M.; Lin, C.M.; Hamel, E. Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. J. Med. Chem., 1992, 35, 2293-2306.
95. Maya, A.B.; Perez-Melero, C.; Mateo, C.; Alonso, D.; Fernandez, J.L.; Gajate, C.; Mollinedo, F.; Pelaez, R.; Caballero, E.; Medarde, M. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety. J. Med. Chem., 2005, 48, 556-568.
96. Flynn, B.L.; Flynn, G.P.; Hamel, E.; Jung, M.K. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4. Bioorg. Med. Chem. Lett, 2001, 11, 2341-2343.
97. Flynn, B.L.; Hamel, E.; Jung, M.K. One-pot synthesis of benzo-[b]furan and indole inhibitors of tubulin polymerization. J. Med. Chem., 2002, 45, 2670-2673.
98. Liou, J.P.; Chang, Y.L.; Kuo, F.M.; Chang, C.W.; Tseng, H.Y.; Wang, C.C.; Yang, Y.N.; Chang, J.Y.; Lee, S.J.; Hsieh, H.P. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. J. Med. Chem., 2004, 47, 4247-4257.
99. Wang, L.; Woods, K.W.; Li, Q.; Barr, K.J.; McCroskey, R.W.; Hannick, S.M.; Gherke, L.; Credo, R.B.; Hui, Y.H.; Marsh, K.; Warner, R.; Lee, J.Y.; Zielinski-Mozng, N.; Frost, D.; Rosenberg, S.H.; Sham, H.L. Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. J. Med. Chem., 2002, 45, 1697-1711.
100. Rubino, S.; Portanova, P.; Albanese, A.; Calvaruso, G.; Orecchio, S.; Fontana, G.; Stocco, G.C. Mono- and polynuclear complexes of Pt(II) with polypyridyl ligands synthesis, spectroscopic and structural characterization and cytotoxic activity. J. Inorg. Biochem., 2007, 101, 1473-1482.
101. Groessl, M.; Reisner, E.; Hartinger, C.G.; Eichinger, R.; Semenova, O.; Timerbaev, A.R.; Jakupec, M.A.; Arion, V.B.; Keppler, B.K. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L) Imidazole, Indazole, 1,2,4-Triazole, 4-Amino-1,2,4-triazole, and 1-Methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity. J. Med. Chem., 2007, 50, 2185-2193.
102. De La Rosa, M.; Kim, H.W.; Gunic, E.; Jenket, C.; Boyle, U.; Koh, Y.-H.; Korboukh, I.; Allan, M.; Zhang, W.; Chen, H.; Xu, W.; Nilar, S.; Yao, N.; Hamatake, R.; Lang, S.A.; Hong, Z.; Zhang, Z.; Girardet, J.-L. Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett., 2006, 16, 4444-4449.
103. Wang, Z.; Wu, B.; Kuhen, K.L.; Bursulaya, B.; Nguyen, T.N.; Nguyen, D.G.; He, Y. Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 4174-4177.
104. Wu, J.; Liu, X.; Cheng, X.; Cao, Y.; Wang, D.; Li, Z.; Xu, W.; Pannecouque, C.; Witvrouw, M.; De Clercq, E. Synthesis of Novel Derivatives of 4-Amino-3-(2-Furyl)-5-Mercapto-1,2,4-Triazole as Potential HIV-1 NNRTIs. Molecules, 2007, 12, 2003-2016.